COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-94063

First 94063 Last

Share
Profile

Follow
Bananabender1

11,738 Posts.

10

04/04/24

16:24

Post #: 73191793
Share

Originally posted by colb: ↑

Hey Banana!!!! Did ya see this on Pfizer's Website as well???

1986: Pfizer had to withdraw an artificial heart valve from the market after defects led to it being implicated in over 300 deaths. The US Food and Drug Administration (FDA) withdrew its approval for the product in 1986 and Pfizer agreed to pay hundreds of millions of dollars in compensation after multiple lawsuits were brought against it.

2003: Pfizer has long been condemned for profiteering from AIDS drugs. In 2003 for example, it walked away from a licencing deal for its Rescriptor drug that would have made it cheaper for poorer countries.

2011: Pfizer was forced to pay compensation to families of children killed in the controversial Trovan drug trial. During the worst meningitis epidemic seen in Africa, in 1996, Pfizer ran a trial in Nigeria their new drug Trovan. Five of the 100 children who took Trovan died and it caused liver damage, while it caused lifelong disabilities in those who survived. But another group of 100 children were given the conventional “gold standard” meningitis antibiotic as a “control” group for comparison. Six of them also tragically died because, the families said, Pfizer had given them less than the recommended level of the conventional antibiotic in order to make Trovan look more effective.

2012: Pfizer had to pay around $1billion to settle lawsuits claiming its Prempro drug caused breast cancer. Prempro was used in hormone replacement therapy, usually for women going through the menopause. The settlements came after six years of trials and hardship for the women affected.

2013: Pfizer paid out $273 million to settle over 2,000 cases in the US that accused its smoking treatment drug Chantix of provoking suicidal and homicidal thoughts, self harm and severe psychological disorders. Pfizer was also accused of improperly excluding patients with a history of depression or other mental disturbances from trials for the drug. Later, in 2017, a coroner in Australia ruled that the drug had contributed to a man’s suicide. The man’s mother campaigned to change the label on the drug.

2020: Pfizer reached an agreement with thousands of customers of its depo-testosterone drug in 2018 after they sued it for increasing the likelihood of numerous issues, including heart attacks.

Expand

Get the Moderna jab then mate if you're that scared...
Upvote

Reply

Top Stories

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

MKG

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

ENV

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

AZY

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

VUL

Vulcan appoints investment bank and M&A veteran to board

MLS

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

There are more pages in this discussion • 7,335 more messages in this thread...

First 94063 Last

COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-94063

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Utah authorities sign off on Anson's lithium extraction plans at Green River

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Vulcan appoints investment bank and M&A veteran to board

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Featured News

Featured News

COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-94063

Top Stories

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Utah authorities sign off on Anson's lithium extraction plans at Green River

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Vulcan appoints investment bank and M&A veteran to board

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Featured News

Featured News